Insulin aspart, recombinant Subcutaneous and Levulan
Determining the interaction of Insulin aspart, recombinant Subcutaneous and Levulan and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
Generic Name: aminolevulinic acid topical
Brand name: Ameluz, Levulan Kerastick
Synonyms: Levulan Kerastick (topical), Levulan Kerastick
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin aspart, recombinant Subcutaneous-Levulan Kerastick
- Insulin aspart, recombinant Subcutaneous-Levulan Kerastick topical
- Insulin aspart, recombinant Subcutaneous-Lexapro
- Insulin aspart, recombinant Subcutaneous-Lexapro (Escitalopram Solution)
- Insulin aspart, recombinant Subcutaneous-Lexapro (Escitalopram Tablets)
- Insulin aspart, recombinant Subcutaneous-Lexazin Capsules
- Levulan-Insulin degludec
- Levulan-Insulin Degludec (U-100) Prefilled Pens
- Levulan-Insulin Degludec (U-100) Vials
- Levulan-Insulin Degludec (U-200) Prefilled Pens
- Levulan-Insulin degludec and liraglutide
- Levulan-Insulin degludec and liraglutide Subcutaneous